Meningococcal groups a, b, c, w, and y vaccine - Biologic Drug Details

Summary for meningococcal groups a, b, c, w, and y vaccine

Tradenames:	1
High Confidence Patents:	13
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for meningococcal groups a, b, c, w, and y vaccine

Recent Clinical Trials for meningococcal groups a, b, c, w, and y vaccine

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Public Health England	Phase 4
National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1

See all meningococcal groups a, b, c, w, and y vaccine clinical trials

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

1. Brand-side disclosures in response to biosimilar applications

These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

2. DrugPatentWatch analysis and brand-side disclosures

These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

3. Patents from broad patent text search

For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for meningococcal groups a, b, c, w, and y vaccine Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for meningococcal groups a, b, c, w, and y vaccine Derived from DrugPatentWatch Analysis and Company Disclosures

These patents were obtained from company disclosures

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Patent No.	Estimated Patent Expiration	Source
Pfizer Ireland Pharmaceuticals Unlimited Company	PENBRAYA	meningococcal groups a, b, c, w, and y vaccine	Injection	125770		2038-11-02	DrugPatentWatch analysis and company disclosures
Pfizer Ireland Pharmaceuticals Unlimited Company	PENBRAYA	meningococcal groups a, b, c, w, and y vaccine	Injection	125770		2040-09-24	DrugPatentWatch analysis and company disclosures
Pfizer Ireland Pharmaceuticals Unlimited Company	PENBRAYA	meningococcal groups a, b, c, w, and y vaccine	Injection	125770		2027-02-28	DrugPatentWatch analysis and company disclosures
Pfizer Ireland Pharmaceuticals Unlimited Company	PENBRAYA	meningococcal groups a, b, c, w, and y vaccine	Injection	125770		2033-02-14	DrugPatentWatch analysis and company disclosures

3) Low Certainty: US Patents for meningococcal groups a, b, c, w, and y vaccine Derived from Patent Text Search

These patents were obtained by searching patent claims

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Patent No.	Estimated Patent Expiration	Source

International Patents for meningococcal groups a, b, c, w, and y vaccine

Country	Patent Number	Estimated Expiration
African Regional IP Organization (ARIPO)	2436
Argentina	053935
Argentina	056396
Argentina	056397

Supplementary Protection Certificates for meningococcal groups a, b, c, w, and y vaccine

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
13C0039	France		PRODUCT NAME: PROTEINE DE FUSION NHBA DE NEISSERIA MENINGITIDIS B; REGISTRATION NO/DATE: EU/1/12/812/001 20130114
38/2012	Austria		PRODUCT NAME: NEISSERIA MENINGITIDIS-GRUPPE A- POLYSACCHARID KONJUGIERT AN TETANUSTOXOID-TRAEGERPROTEIN; NAT. REGISTRATION NO/DATE: EU/1/12/767001 - 007 20120425; FIRST REGISTRATION: EU/1/12/767/001 - 007 20120425
132013902171317	Italy		PRODUCT NAME: PROTEINA DI FUSIONE NHBA DI NEISSERIA MENINGITIDIS GRUPPO B(BEXSERO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/12/812/001-004, 20130114
SPC/GB17/063	United Kingdom		PRODUCT NAME: NEISSERIA MENINGITIDIS SEROGROUP B FHBP SUBFAMILY A AND NEISSERIA MENINGITIDIS SEROGROUP B FHBP SUBFAMILY B; REGISTERED: UK EU/1/17/1187 20170530